[{"name":"Brain metastasis as a target","mode":"","is_cme":false,"info":{"presentation":"Brain metastasis as a target","session":"Session 6: Efficacy evaluation of Immune Check Points Inhibitors: Recist 1.1, iRecist or Ir Recist? The issue and risk of hyper-progression","presenter":"A. Marabelle","photo":null},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/lung2019\/11\/v\/13_1c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/lung2019\/11\/v\/13_1c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/lung2019\/11\/v\/13_1c.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"8L240e02VK"}